Trachoma

  • Medical Author:
    Frank J. Weinstock, MD, FACS

    Dr. Weinstock is a board-certified ophthalmologist. He practices general ophthalmology in Canton, Ohio, with a special interest in contact lenses. He holds faculty positions of Professor of Ophthalmology at the Northeastern Ohio Colleges of Medicine and Affiliate Clinical Professor in the Charles E. Schmidt College of Biomedical Science at Florida Atlantic University.

  • Medical Editor: Andrew A. Dahl, MD, FACS
    Andrew A. Dahl, MD, FACS

    Andrew A. Dahl, MD, FACS

    Andrew A. Dahl, MD, is a board-certified ophthalmologist. Dr. Dahl's educational background includes a BA with Honors and Distinction from Wesleyan University, Middletown, CT, and an MD from Cornell University, where he was selected for Alpha Omega Alpha, the national medical honor society. He had an internal medical internship at the New York Hospital/Cornell Medical Center.

What research is being done on trachoma?

Since the cause is well understood and treatment is effective, research is concentrating on methodology to deliver the treatment efficiently to endemic areas of the world.

Medically reviewed by William Baer, MD; Board Certified Ophthalmology

REFERENCES:

Bailey, R.L., P. Arullendran, H.C. Whittle, and D.C. Mabey. "Randomised Controlled Trial of Single-Dose Azithromycin in Treatment of Trachoma." Lancet 342.8869 Aug. 21, 1993: 453-456.

International Trachoma Initiative. <http://www.trachoma.org>.

Solomon, A.W., R.W. Peeling, A. Foster, and D.C.W. Mabey. "Diagnosis and Assessment of Trachoma." Clin Microbiol Rev. 17.4 Oct. 2004: 982-1011.

Subscribe to MedicineNet's Newsletters

Get the latest health and medical information delivered direct to your inbox!

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

Health Solutions From Our Sponsors